AegirBio AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was SEK 4.87 million compared to SEK 15.19 million a year ago. Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.69 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.636 SEK | +3.25% | +6.00% | -45.64% |
1st Jan change | Capi. | |
---|---|---|
-45.64% | 21.77L | |
+7.01% | 22TCr | |
+11.01% | 19TCr | |
+19.20% | 14TCr | |
+30.79% | 11TCr | |
+1.48% | 6.46TCr | |
+13.95% | 5.24TCr | |
-0.16% | 4.85TCr | |
-6.20% | 3.8TCr | |
+0.91% | 3.56TCr |
- Stock Market
- Equities
- AEGIR Stock
- News AegirBio AB
- AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024